Creative Medical Technology Holdings, Inc. (CELZ)
0.623
+0.02
(+2.81%)
USD |
NASDAQ |
Nov 06, 10:29
Creative Medical Technology Holdings Price to Book Value : 0.4673 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 0.4545 |
| November 04, 2026 | 0.489 |
| November 03, 2026 | 0.5052 |
| November 02, 2026 | 0.4677 |
| October 30, 2026 | 0.4913 |
| October 29, 2026 | 0.5089 |
| October 28, 2026 | 0.5401 |
| October 27, 2026 | 0.5177 |
| October 26, 2026 | 0.5341 |
| October 23, 2026 | 0.5551 |
| October 22, 2026 | 0.5806 |
| October 21, 2026 | 0.5569 |
| October 20, 2026 | 0.5661 |
| October 19, 2026 | 0.5428 |
| October 16, 2026 | 0.5558 |
| October 15, 2026 | 0.6134 |
| October 14, 2026 | 0.5793 |
| October 13, 2026 | 0.615 |
| October 12, 2026 | 0.6308 |
| October 09, 2026 | 0.6289 |
| October 08, 2026 | 0.6454 |
| October 07, 2026 | 0.6668 |
| October 06, 2026 | 0.6754 |
| October 05, 2026 | 0.6901 |
| October 02, 2026 | 0.7099 |
| Date | Value |
|---|---|
| October 01, 2026 | 0.7064 |
| September 30, 2026 | 0.701 |
| September 29, 2026 | 0.724 |
| September 28, 2026 | 0.7576 |
| September 25, 2026 | 0.7726 |
| September 24, 2026 | 0.7276 |
| September 23, 2026 | 0.7304 |
| September 22, 2026 | 0.7051 |
| September 21, 2026 | 0.7538 |
| September 18, 2026 | 0.7245 |
| September 17, 2026 | 0.6582 |
| September 16, 2026 | 0.6166 |
| September 15, 2026 | 0.6638 |
| September 14, 2026 | 0.6585 |
| September 11, 2026 | 0.7205 |
| September 10, 2026 | 0.7127 |
| September 09, 2026 | 0.7801 |
| September 08, 2026 | 0.8101 |
| September 04, 2026 | 0.8326 |
| September 03, 2026 | 0.7951 |
| September 02, 2026 | 0.8476 |
| September 01, 2026 | 0.8251 |
| August 31, 2026 | 0.8476 |
| August 28, 2026 | 0.8551 |
| August 27, 2026 | 0.8551 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.751 |
| Alnylam Pharmaceuticals, Inc. | 5.890 |
| Anika Therapeutics, Inc. | 1.543 |
| Savara, Inc. | 6.677 |
| Vericel Corp. | 7.167 |
Price to Book Value Related Metrics
| PS Ratio | 710.25 |
| Price | 0.623 |
| Earnings Yield | -285.3% |
| Market Cap | 4.044M |